Related Experiment Video

Updated: Aug 11, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

IL-7 promotes T cell proliferation through destabilization of p27Kip1

Wen Qing Li1, Qiong Jiang, Eiman Aleem

  • 1Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Frederick, MD 21702, USA.

The Journal of Experimental Medicine
|February 24, 2006
PubMed

Insights

Interleukin-7 (IL-7) maintains T cell proliferation via a novel pathway involving p27Kip1 regulation. IL-7 withdrawal causes cell cycle arrest, mediated by protein kinase C theta (PKCθ), not the conventional pathway.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Interleukin-7 (IL-7) is crucial for T lymphocyte survival and proliferation.
  • The precise mechanism by which IL-7 promotes T cell proliferation remains unclear.
  • It is debated whether IL-7 directly signals proliferation or if it's a consequence of its survival effects.

Purpose of the Study:

  • To elucidate the mechanism of IL-7-mediated T cell proliferation.
  • To determine if IL-7 receptor signaling directly drives proliferation.
  • To investigate the role of p27Kip1 and protein kinase C theta (PKCθ) in IL-7's proliferative effects.

Main Methods:

  • Utilized an IL-7-dependent T cell line and primary CD4/CD8 T cells.
  • Employed gene knockdown with small interfering RNA (siRNA) for p27Kip1.
  • Applied pharmacological inhibition of PKCθ.
  • Assessed cell cycle arrest (G1) and proliferation (S phase entry) via IL-7 withdrawal and manipulation of key proteins.

Main Results:

  • IL-7 withdrawal induced G1 cell cycle arrest in T cells, even when apoptosis was inhibited.
  • This arrest was linked to post-translational upregulation of p27Kip1.
  • Knockdown of p27Kip1 rescued proliferation after IL-7 withdrawal.
  • IL-7 withdrawal activated PKCθ, which mediated p27Kip1 upregulation and G1 arrest via a novel pathway.

Conclusions:

  • IL-7 maintains T cell proliferation through a previously unrecognized pathway.
  • This pathway involves PKCθ-mediated regulation of p27Kip1, distinct from the conventional p27Kip1 degradation route.
  • PKCθ activation by IL-7 withdrawal is critical for inducing G1 arrest in T cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...